Last year I was interviewed for an episode of the Juicebox Podcast, a T1-focussed podcast from the US. That episode (which Scott titled “APS Wookie“) is now online. We talk at length about a variety of issues: of course including my use of a “fully-closed loop” AID system. So if you want to hear what …
It’s the start of another month, and this time the NDSS Insulin Pump Consumables (IPC) list has been updated. The “Pump Infusion Sets” page on this site (which you can find via the menu at the top of most pages) has been updated to match. I hope it remains a useful reference. Notable changes include …
The 2023 Fiasp supply dramas are entering a new phase. We have an opportunity to contribute to the process in the next week. Scroll on and you’ll find details. But first, some background. Or jump ahead if you’re in a hurry…. History recap In June 2019 Fiasp was added to the Australian Pharmaceutical Benefits Scheme …
This article is a general education one, but it’s also reference material for an upcoming discussion on insulin availability. In Australia most insulins have been available in up to three formats: 10 mL vials. Traditionally used for syringe injections and filling pumps. 3 mL pen cartridges. Put into pens for injections. Some people also use …
This is a follow-on from my “Adjunctive therapies” article. If you haven’t read that yet, please do so before proceeding. Here I’m going to talk about a few of the medications that people already take in parallel with insulin use. Not all of them of course (only statins, fibrates, and metformin) but there are other …
As people living with Type 1 Diabetes we’re used to the concepts of dosing ourselves with insulin and how that interacts with food, exercise, and our BG levels. It can be very convoluted, with many subtle factors sometimes having significant effect on our BG. But is the world as straightforward as “only” striving for perfect …